CELC241220C22500
- 0.60
- 0.000.00%
Celcuity Newsroom
Analysts Have Conflicting Sentiments on These Healthcare Companies: Hims & Hers Health (HIMS) and Celcuity (CELC)
A Quick Look at Today's Ratings for Celcuity(CELC.US), With a Forecast Between $27 to $42
Celcuity Price Target Maintained With a $27.00/Share by HC Wainwright & Co.
Celcuity Down Over 12%, on Pace for Largest Percent Decrease Since October 2023 -- Data Talk
Stifel Nicolaus Remains a Buy on Celcuity (CELC)
A Quick Look at Today's Ratings for Celcuity(CELC.US), With a Forecast Between $23 to $27
Celcuity's Strong Financial Position and Promising Drug Pipeline Support Buy Rating Despite Trial Delays
Express News | Needham Reiterates Buy on Celcuity, Maintains $23 Price Target
Celcuity Analyst Ratings
Express News | Celcuity Inc : Leerink Partners Cuts Target Price to $28 From $29
Celcuity Inc. (CELC) Q3 2024 Earnings Call Transcript Summary
Promising Outlook for Celcuity's Gedatolisib Highlighted by Positive Phase III Trial Progress
Celcuity | 10-Q: Q3 2024 Earnings Report
Celcuity Reports Q3 EPS (70c), Consensus (70c)
Celcuity GAAP EPS of -$0.70 Misses by $0.05
Celcuity | 8-K: Celcuity Inc. Reports Third Quarter Financial Results and Provides Corporate Update
Earnings Flash (CELC) CELCUITY Posts Q3 Loss $-0.65
Press Release: Celcuity Inc. Reports Third Quarter Financial Results and Provides Corporate Update
Express News | Celcuity Q3 Operating Expenses USD 30.1 Million
Express News | Celcuity Q3 Adjusted Net Income USD -27.6 Million Vs. IBES Estimate USD -24.9 Million